Universal Cervical Length Screening for Prediction and Prevention of Preterm Birth
- 1 October 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (10) , 653-657
Abstract
Universal transvaginal ultrasound (TVU) cervical length (CL) screening represent a step forward in the campaign against preterm birth (PTB). Transvaginal ultrasound CL is a safe, acceptable, reproducible, and accurate screening test, with potentially widespread availability given its feasibility. For this screening to be effective, the ultrasounds should be done with proper TVU technique and with continuing quality assurance. Clinicians should refrain from screening different populations, at different gestational ages, and from stretching the definition of short CL to include measurements above 25 mm. A single TVU CL measurement at about 18 to 24 6/7 weeks can be offered to all singleton gestations. About 2% to 5% of these women will demonstrate a TVU CL of 20 mm or less and should be offered vaginal progesterone, either 200-mg suppository or 90-mg gel daily, until 36 weeks, being counseled that this intervention has been associated with about 45% decrease in PTB and neonatal benefits. Serial TVU CL measurements, about every 2 weeks and weekly if CL is 25 to 29 mm, can be offered between about 16 and 23 6/7 weeks to singleton gestations with a prior spontaneous PTB. In the 40% of these women who will develop a short TVU CL of less than 25 mm, cerclage should be offered, as it is associated with a significant 30% reduction in the risk of PTB less than 35 weeks and a 36% reduction in composite perinatal mortality and morbidity. Transabdominal CL screening has not been sufficiently studied and cannot be recommended. Results from just 1 trial offer promise for pessary as another effective intervention, which cannot be recommended yet until results are confirmed with another trial. Transvaginal ultrasound CL in multiples cannot be recommended yet, given lack of effective interventions in this population.Keywords
This publication has 13 references indexed in Scilit:
- Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trialUltrasound in Obstetrics & Gynecology, 2011
- Universal cervical‐length screening to prevent preterm birth: a cost‐effectiveness analysisUltrasound in Obstetrics & Gynecology, 2010
- ACOG Committee Opinion No. 419: Use of Progesterone to Reduce Preterm BirthObstetrics & Gynecology, 2008
- Progesterone and the Risk of Preterm Birth among Women with a Short CervixNew England Journal of Medicine, 2007
- Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United StatesObstetrics & Gynecology, 2005
- Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone CaproateNew England Journal of Medicine, 2003
- Mid-Trimester Endovaginal Sonography in Women at High Risk for Spontaneous Preterm BirthJAMA, 2001
- The preterm prediction study: Risk factors in twin gestationsAmerican Journal of Obstetrics and Gynecology, 1996
- The Length of the Cervix and the Risk of Spontaneous Premature DeliveryNew England Journal of Medicine, 1996
- Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists Multicentre Randomised Trial of Cervical CerclageBJOG: An International Journal of Obstetrics & Gynaecology, 1993